APPLICATION
ANDA209096
TYPE
ANDA
ORIGINAL APPROVAL
2017-09-12
LATEST ACTION
2024-07-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
METRONIDAZOLEDiscontinued
METRONIDAZOLE 250MG · TABLET · ORAL
METRONIDAZOLEDiscontinued
METRONIDAZOLE 500MG · TABLET · ORAL
Approval history
2024-07-08Labeling · Supplement 5 · standardAP
2023-12-18Labeling · Supplement 4 · standardAP
2022-03-31Labeling · Supplement 3 · standardAP
2021-08-19Labeling · Supplement 2 · standardAP
2019-07-29Labeling · Supplement 1 · standardAP
2017-09-12UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.